Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARA
726
DELISTED
Paramount Global Class B
PARA
| $35.5M | 0.01% |
3,417,435
-607,075
| -15% | -$7.11M |
|
727
Nutrien
NTR
$33.2B
| $35.5M | 0.01% |
696,447
+609,118
| +697% | +$33.4M |
|
|
728
CALL
Procter & Gamble
PG
$336B
| $35.4M | 0.01% |
214,800
+159,800
| +291% | +$26.1M |
|
729
CALL
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $35.4M | 0.01% |
+399,900
| New | +$35.5M |
|
730
CALL
Boot Barn
BOOT
$4.51B
| $35.3M | 0.01% |
+273,800
| New | +$30.8M |
|
731
Plains All American Pipeline
PAA
$17.3B
| $35.3M | 0.01% |
1,976,260
+431,346
| +28% | +$7.53M |
|
732
Steris
STE
$22.3B
| $35.2M | 0.01% |
160,559
+11,649
| +8% | +$2.53M |
|
733
Align Technology
ALGN
$12.1B
| $35.1M | 0.01% |
145,496
-128,522
| -47% | -$35.8M |
|
734
Baxter International
BAX
$13.5B
| $35M | 0.01% |
1,046,798
-241,190
| -19% | -$8.89M |
|
735
Textron
TXT
$14.7B
| $35M | 0.01% |
407,686
-131,917
| -24% | -$11.7M |
|
736
Las Vegas Sands
LVS
$31.7B
| $35M | 0.01% |
790,443
-239,804
| -23% | -$11.2M |
|
737
Enterprise Products Partners
EPD
$82.3B
| $34.9M | 0.01% |
1,205,746
+168,843
| +16% | +$4.84M |
|
738
Invesco
IVZ
$13.1B
| $34.8M | 0.01% |
2,329,143
+277,347
| +14% | +$4.26M |
|
739
CALL
West Pharmaceutical
WST
$24B
| $34.8M | 0.01% |
+105,500
| New | +$37.3M |
|
740
Ameren
AEE
$30.3B
| $34.7M | 0.01% |
488,079
-122,226
| -20% | -$8.89M |
|
741
CenterPoint Energy
CNP
$27.7B
| $34.6M | 0.01% |
1,118,175
-511,225
| -31% | -$15.1M |
|
742
CALL
Wayfair
W
$11.2B
| $34.5M | 0.01% |
655,000
+504,300
| +335% | +$29.9M |
|
743
Waters Corp
WAT
$37B
| $34.4M | 0.01% |
118,656
-3,970
| -3% | -$1.27M |
|
744
Toro Company
TTC
$8.75B
| $34.4M | 0.01% |
368,076
-281,818
| -43% | -$24.9M |
|
|
WBA
745
DELISTED
Walgreens Boots Alliance
WBA
| $34.3M | 0.01% |
2,833,743
-908,076
| -24% | -$15.4M |
|
746
Credicorp
BAP
$31.8B
| $34.2M | 0.01% |
211,745
+3,827
| +2% | +$633K |
|
747
Zebra Technologies
ZBRA
$14B
| $34.2M | 0.01% |
110,560
+2,826
| +3% | +$859K |
|
748
Charles River Laboratories
CRL
$11.2B
| $34.1M | 0.01% |
165,205
+51,731
| +46% | +$11.7M |
|
749
CALL
Synchrony
SYF
$24.7B
| $33.7M | 0.01% |
715,000
-180,700
| -20% | -$7.85M |
|
750
Amcor
AMCR
$20.8B
| $33.7M | 0.01% |
689,491
+159,573
| +30% | +$7.74M |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.